dr. usmani on current challenges in high-risk multiple myeloma
Published 4 years ago • 254 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:43
high-risk multiple myeloma: addressing challenges and unmet needs
-
0:47
dr. usmani on key findings from the swog 1211 trial in high-risk multiple myeloma
-
0:53
dr. usmani on situations that indicate the need for immediate treatment in r/r multiple myeloma
-
2:03
dr. usmani on the dreamm trials in multiple myeloma
-
1:28
dr. usmani on minimal residual disease in multiple myeloma
-
0:59
dr. usmani on treatment of newly diagnosed myeloma
-
2:05
dr. usmani on treatment considerations in relapsed/refractory multiple myeloma
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
1:37
dr. usmani on car t cells, bispecific antibodies, and adcs in multiple myeloma
-
1:15
dr. usmani on mechanisms and response rates with daratumumab in myeloma
-
0:57
dr. usmani on potential of checkpoint inhibitors in multiple myeloma
-
1:57
challenges in treating frail, older patients with myeloma: high-risk patients & toxicity management
-
1:18
dr. stadtmauer on current challenges with multiple myeloma
-
13:21
clinical trial enrollment challenges in multiple myeloma (impact podcast)
-
1:55
dr. usmani on ibrutinib/carfilzomib in patients with multiple myeloma
-
1:48
dr. usmani on subcutaneous delivery of daratumumab in myeloma
-
0:45
dr. usmani discusses management of early relapse in myeloma
-
27:42
m-power ny | drs. joseph mikhael and saad usmani on clinical trials: why would i participate?
-
1:06
dr. usmani on importance of castor/pollux trials in myeloma